PreludeDx Reveals Data | DCISionRT Reduces Radiation Therapy for DCIS
Delve into the revolutionary impact of DCISionRT in guiding radiation therapy for ductal carcinoma in situ (DCIS) patients. Prelude Corporation unveils groundbreaking data at the ASBrS Annual Meeting, highlighting the integration of molecular insights…
Continue Reading